Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection
出版年份 2021 全文链接
标题
Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection
作者
关键词
-
出版物
Pathogens and Global Health
Volume -, Issue -, Pages 1-8
出版商
Informa UK Limited
发表日期
2021-03-08
DOI
10.1080/20477724.2021.1890887
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer
- (2020) Sundy N.Y. Yang et al. ANTIVIRAL RESEARCH
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The COVID‐19 epidemic
- (2020) Thirumalaisamy P. Velavan et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China
- (2020) Rossella Porcheddu et al. Journal of Infection in Developing Countries
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China
- (2020) Yan Deng et al. CHINESE MEDICAL JOURNAL
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
- (2020) Rong-Hui Du et al. EUROPEAN RESPIRATORY JOURNAL
- Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
- (2020) Ming Zhao INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin
- (2020) Alberto Cipriani et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The SARS-CoV-2 outbreak: What we know
- (2020) Di Wu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
- (2020) Khan Sharun et al. Annals of Clinical Microbiology and Antimicrobials
- Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
- (2020) Wei Tang et al. BMJ-British Medical Journal
- Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
- (2020) Ren Mao et al. Lancet Gastroenterology & Hepatology
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- COVID-19, SARS and MERS: are they closely related?
- (2020) N. Petrosillo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
- (2020) Fatemeh Heidary et al. JOURNAL OF ANTIBIOTICS
- Risk Factors for Mortality in Patients with COVID-19 in New York City
- (2020) Takahisa Mikami et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- (2020) Alexandre B. Cavalcanti et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 viral load predicts COVID-19 mortality
- (2020) Elisabet Pujadas et al. Lancet Respiratory Medicine
- COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge
- (2020) Jacek Baj et al. Journal of Clinical Medicine
- Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus
- (2018) Tie-Long Xu et al. PLoS Neglected Tropical Diseases
- Obesity-Induced TNFα and IL-6 Signaling: The Missing Link between Obesity and Inflammation—Driven Liver and Colorectal Cancers
- (2018) Lara Kern et al. Cancers
- A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
- (2016) Nicholas J. Barrows et al. Cell Host & Microbe
- Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import
- (2016) Veronika Götz et al. Scientific Reports
- Ivermectin inhibits porcine reproductive and respiratory syndrome virus in cultured porcine alveolar macrophages
- (2015) Yoo Jin Lee et al. ARCHIVES OF VIROLOGY
- The role of adipose tissue immune cells in obesity and low-grade inflammation
- (2014) Milos Mraz et al. JOURNAL OF ENDOCRINOLOGY
- Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
- (2012) Kylie M. Wagstaff et al. BIOCHEMICAL JOURNAL
- Dynamics of a Cytokine Storm
- (2012) Hao Hong Yiu et al. PLoS One
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
- (2008) G Ruiz-Irastorza et al. ANNALS OF THE RHEUMATIC DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started